Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT
Status:
Recruiting
Trial end date:
2021-12-20
Target enrollment:
Participant gender:
Summary
Low dose Rabbit Antithymocyte Globulin plus Low-dose post-transplantation cyclophosphamide as
graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell
transplantation for patients with hematologic malignancies
Phase:
Phase 2
Details
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine